The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Suppose the short answer is risk and unknowns. If the FSP lands tomorrow and says sold for x then no risk or unknowns.
Currently we are valued totally around the FSP potential, otherwise you would have to look at fundamentals, which in EUA case is as an exploration company with very little revenue but useful forward revenue growth.
My tuppance
Is there enough in the RNS to bring in new investors though? I think mjng I would partially agree with you and that the company is "potentially seriously under valued".
Yes, cash was seriously needed to realise that potential and we remain optimistic but IMO for the SP to rise from hete we need some serious good news; either Eli deal or productisation roadmap from positive clinical results.
The filter button is a good feature. I would recommend we all use it. Means you don't see the rubbish spouted. Whatever you don't know, you never miss! If applied properly, this BB would no longer be clogged up with all this whingeing! Yes you would see a lot of green boxes initially but the whingers would get fed up with no responses and just go away. Simples :)
Was that not something related to **** tbat Rowka talked about JM? Something that needed some sort of wash processing of the **** that we had an abundance of. Seem to recall something about that alright.
As you say jh4h, they have lots of potential research pipelines but until these are converted into real revenue generating products, they are just pipedreams. Some might even argue that too many pipelines could be resource and energy draining, and that hemo should focus more. It is just my read, I could of course be wrong. If positive news drops all will be good but until then this heads south IMO.